Bright Minds Biosciences Inc.
DRUG | NASDAQ
$61.02
+$1.56 (+2.62%)
Sep 22, 2026, 1:12 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 308.16M | 309.3M | 89.05M | 82.91M | 51.39M | 55.68M | 57.9M | 5.72M | 6.19M | 5.93M | 6.76M | 6.75M | 8.13M | 9.67M | 11.21M | 11.63M | 8.64M | 11.47M | 15.12M | 19.76M | 22.01M | 25.45M | 2.06M |
Short-Term Investments | 172.78K | 172.38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33.68K | 33.68K | 33.68K | 33.68K | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 0 | 0 | 0 | 0 | 0 | n/a | n/a | -33.68K | -33.68K | -33.68K | -33.68K | n/a |
Receivables | 1.1M | 1.14M | 502.68K | 413.07K | 272.63K | 233.57K | 67.02K | 50.22K | 17.24K | 553.25K | 45.04K | 36.98K | 103.68K | 33.36K | 59.28K | 155.78K | 96.44K | 208.4K | 149.69K | 110.15K | 77.98K | 36.75K | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -263 |
Total Current Assets | 310.79M | 312.07M | 90.79M | 84.31M | 52.37M | 56.31M | 58.22M | 5.99M | 6.27M | 6.5M | 6.84M | 6.81M | 8.38M | 9.88M | 11.43M | 11.95M | 8.82M | 11.76M | 15.41M | 20.04M | 22.21M | 25.74M | 2.18M |
Property-Plant & Equipment | 53.01K | 72.33K | 92.18K | 111.97K | 128.98K | 154.51K | 176.99K | 117.66K | 12.08K | 30.19K | 48.3K | 66.41K | 84.53K | 102.64K | 120.75K | 138.86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 2K | 2K | 2K | 2K | 2K | 2K |
Total Long-Term Assets | 53.01K | 72.33K | 92.18K | 111.97K | 128.98K | 154.51K | 176.99K | 117.66K | 12.08K | 30.19K | 48.3K | 66.41K | 84.53K | 102.64K | 120.75K | 138.86K | 2K | 2K | 2K | 2K | 2K | 2K | 2K |
Total Assets | 310.84M | 312.15M | 90.88M | 84.42M | 52.5M | 56.47M | 58.4M | 6.1M | 6.28M | 6.53M | 6.89M | 6.88M | 8.46M | 9.99M | 11.55M | 12.09M | 8.82M | 11.76M | 15.41M | 20.04M | 22.22M | 25.74M | 2.18M |
Account Payables | n/a | 3.63M | 1.43M | 1.71M | 510.8K | 551.22K | 373.63K | 407.55K | 149.61K | 801.06K | 799.6K | 182.31K | 643.4K | 247.95K | 322.17K | 1.25M | 385.32K | 994.82K | 482.6K | 596.57K | 322.86K | 409.24K | 95.39K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 65.7K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 2.48M | -2.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | n/a | n/a | n/a | n/a | n/a | n/a | 0 | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 2.55M | 3.83M | 1.58M | 2.34M | 604.99K | 637.97K | 461.52K | 528.68K | 178.63K | 845.79K | 854.16K | 280.86K | 720.8K | 1.01M | 528.1K | 1.47M | 385.32K | 1M | 489.6K | 638.57K | 322.86K | 409.24K | 95.39K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | 16.74K | 41.25K | 62.84K | 88.85K | 110.07K | 39.58K | n/a | n/a | n/a | n/a | 14.02K | 34.73K | 54.56K | 71.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Liabilities | 2.55M | 3.83M | 1.6M | 2.38M | 667.83K | 726.81K | 571.59K | 568.26K | 178.63K | 845.79K | 854.16K | 280.86K | 734.81K | 1.04M | 582.66K | 1.54M | 385.32K | 1M | 489.6K | 638.57K | 322.86K | 409.24K | 95.39K |
Total Debt | 65.7K | 82.07K | 104.9K | 125.78K | 141.03K | 166.6K | 182.73K | 118.96K | 14.02K | 34.73K | 54.56K | 73.55K | 91.41K | 108.32K | 124.48K | 139.91K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Book Value | 308.3M | 308.32M | 89.28M | 82.04M | 51.83M | 55.74M | 57.83M | 5.54M | 6.1M | 5.69M | 6.03M | 6.6M | 7.73M | 8.95M | 10.97M | 10.54M | 8.43M | 10.76M | 14.92M | 19.4M | 21.89M | 25.33M | 2.09M |
Book Value Per Share | 31.36 | 32.15 | 11.50 | 11.45 | 7.32 | 11.99 | 12.44 | 1.19 | 1.31 | 1.27 | 1.57 | 1.75 | 2.05 | 2.36 | 3.06 | 3.53 | 3.55 | 4.54 | 6.30 | 8.20 | 9.67 | 18.28 | 1.80 |
Common Stock | 366.58M | 365.52M | 136.77M | 123.25M | 89.91M | 89.89M | 89.02M | 35.42M | 35.05M | 35.05M | 35.05M | 33.91M | 33.91M | 33.91M | 33.68M | 32.24M | 27.19M | 27.17M | 27.18M | 27.08M | 27.05M | 27.24M | 3M |
Retained Earnings | -67.11M | -64.56M | -54.14M | -46.58M | -42.49M | -37.25M | -34.3M | -34.35M | -33.58M | -33.81M | -33.23M | -31.55M | -30.02M | -28.56M | -26.51M | -24.17M | -21.21M | -18.56M | -14.07M | -9.21M | -6.34M | -2.81M | -1.31M |
Comprehensive Income | 8.83M | 7.35M | 6.65M | 5.37M | 4.41M | 3.1M | 3.11M | 4.01M | 3.8M | 3.61M | 3.39M | 3.4M | 3M | 2.76M | 2.96M | 2.48M | 2.45M | 2.15M | 1.85M | 1.57M | 1.22M | 925.55K | 397.72K |
Shareholders Equity | 308.3M | 308.32M | 89.28M | 82.04M | 51.83M | 55.74M | 57.83M | 5.54M | 6.1M | 5.69M | 6.03M | 6.6M | 7.73M | 8.95M | 10.97M | 10.54M | 8.43M | 10.76M | 14.92M | 19.4M | 21.89M | 25.33M | 2.09M |
Total Investments | 172.78K | 172.38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33.68K | 33.68K | 33.68K | 33.68K | n/a |
Add to Watchlist
Select watchlists to add or remove DRUG